LivHOME launches remote monitoring technology
LOS ANGELES – LivHOME Inc., a provider of integrated care management and caregiving services, has launched LivHOME Connect for remote monitoring. From a secure tablet in the client’s home, LivHOME Connect offers immediate face-to-face remote communication with a LivHOME Connect advisor; increased engagement with a dedicated life care manager; regular medication reminders; unlimited video calls with family and friends; and an accessible mobile-friendly application. “The integration of LivHOME Connect into our nationally recognized, professionally led in-home care service model increases the quality and quantity of care management interactions with clients, improving outcomes as well as client and family satisfaction,” said Steve Barlam, chief professional officer and co-founder of LivHOME, in a statement.
Isabel Healthcare, QuestionDoctors partner for crowdsourced physician network
ANN ARBOR, Mich. and QUEBEC, Canada – Isabel Healthcare and QuestionDoctors.com have partnered to make the Isabel Symptom Checker available to all users of their crowdsourced network of physician services. “Consumers are turning more and more to the Internet to research information around diagnoses so the opportunity is to direct them to trusted sites rather than general searching to get their information,” stated Don Bauman, CEO of Isabel Healthcare, in a statement. “Providing access to the Isabel Symptom Checker to the users of the Question Doctors.com site assists with engaging them in their health care and further empowering them to have informed conversations with providers.” The Isabel Symptom Checker allows input with free text natural language, and each diagnosis provided is linked to consumer-level medical information.
ProtoCentral crowdfunds for heart ECG patch
BENGALURU, India – Open-source hardware provider ProtoCentral is crowdfunding for its HeartyPatch single lead electrocardiogram patch. The device can calculate heart rate, R-R intervals and heart rate variability, and the data can be connected to the Internet of Things via Bluetooth. HeartyPatch also works with a mobile app for a Cloud-connected HRV monitor. By making the HeartyPatch project open-source and available, ProtoCentral intends to lower the barriers of entry to heart rate variability studies without worrying about intellectual property, according to the startup’s crowdfunding page.
Solera Health, ADA team to streamline access to DPPs
PHOENIX – Preventive care benefits manager Solera Health and the American Diabetes Association have partnered to provide people at risk for diabetes with access to a Diabetes Prevention Program recognized by the Centers for Disease Control and Prevention.
The initiative seeks to help adults at risk for Type 2 diabetes prevent or delay the onset of the condition by providing a streamlined process to enroll in a community or digital DPP.
“At the ADA, we are focused on preventing, curing and improving the lives of all people affected by diabetes,” said Tamara Darsow, senior vice president of research and consumer programs at the ADA, in a statement. “By helping us connect people who are at risk with the right DPP to help them prevent or delay the onset of Type 2 diabetes, Solera is helping us achieve that mission.”
Through the collaboration, people who take the ADA’s Type 2 Diabetes Risk Test will now have access to Solera Health’s Solera4Me website, where they can begin the process of being matched with a DPP based on their unique needs and preferences.
The National DPP is a partnership of public and private organizations working together to reduce the growing number of Americans with and at risk for pre-diabetes and Type 2 diabetes. According to the ADA, there are currently more than 1,500 DPPs, including brick-and-mortar locations like community non-profits, health systems, retail pharmacies and faith-based organizations, as well as virtual DPPs, that deliver content to mobile devices, computers and/or telephones.
“Solera is honored to join forces with the American Diabetes Association as both organizations have many synergies that will enhance access to the Diabetes Prevention Program,” said Brenda Schmidt, CEO of Solera Health, in a statement. “By combining the ADA’s influence and reach with our breadth of DPP providers and health plan reimbursement for DPP as a covered medical benefit, we can have a positive impact on delaying or preventing diabetes for a large portion of America’s population.”
Researchers to study mobile app for prostate cancer survivorship
TORONTO – A team of researchers from eHealth Innovation at University Health Network are studying how an mHealth app for prostate cancer survivorship care is adopted and accepted by patients, caregivers and clinicians. “This will, to our knowledge, be the first realist case study to evaluate an app for prostate cancer survivorship care,” said Dr. Joseph Cafazzo, research team leader, in a statement. The team will also determine the effect of the app, called Ned (No Evident Disease), on health-related quality of life, satisfaction with cancer care, unmet needs, self-efficacy and prostate cancer-related levels of anxiety. The Ned case study is a 12-month study of 400 patients, 200 clinicians and 10 clinicians. The first participant was recruited this month and completion of the study is expected in May of 2019.
Purdue Pharma, Geisinger to study mHealth effect on chronic pain
STAMFORD, Conn. and DANVILLE, Pa. – The first patient has been enrolled in a joint Purdue Pharma/Geisinger study on the effects of wearables on treating chronic pain. The study is designed to demonstrate how the use of wearable health technology by chronic pain patients treated at a specialty clinic may improve both patient and healthcare system outcomes. The study will use an Apple Watch to take measures to guide the patient toward non-pharmaceutical treatment alternatives. “The goal of this technology is to improve patient function and quality of life while reducing the need for analgesic medications,” said Dr. Tracy Mayne, head of strategic research at Purdue Pharma, in a statement. The Apple Watch will include a pain app developed for this study and a healthcare provider dashboard, and will integrate with Geisinger’s electronic medical record. “We are incorporating advanced technology into the traditional healthcare setting to redirect and empower the patient to take more control of their own well-being,” said Dr. John Han, director of the department of pain medicine at Geisinger, in a statement.
mHealth study suspended due to low participation
MIDDLETOWN, Conn. – Lack of participation has suspended a study to evaluate the effectiveness of mHealth apps in supporting patients’ health management, according to researchers who recently published an article in JMIR Human Factors. “This brief trial underscores the pitfalls in the utilization of mHealth apps,” wrote Kathleen Thies, one of the researchers, in the article. The study required patients to enter clinical data into an app, where they could communicate with providers. After four months of recruitment, the study was suspended due to low enrollment and inconsistent use of the app, and the aim of the project was changed to understanding why it was unsuccessful. “Effective use of mHealth tools requires a good fit between the app, the users’ electronic health literacy, the treatment approach, staff time and reimbursement for services,” Thies wrote. “We recommend that researchers address contextual factors in the trial and adoption of mHealth technologies.”